TABLE 1: Baseline Characteristics and Univariate Analysis
====================================================================================================

+----------------------------------+----------------+----------------+--------------------+-----------+
| Characteristic                   | LAA Clot (+)   | LAA Clot (-)   | OR (95% CI)        |   P-value |
|                                  | n=85           | n=436          |                    |           |
+==================================+================+================+====================+===========+
| Age, mean ± SD (years)           | 67.0 ± 10.1    | 63.6 ± 12.0    | —                  |     0.016 |
+----------------------------------+----------------+----------------+--------------------+-----------+
| Male sex, n (%)                  | 25 (29.4%)     | 112 (25.7%)    | 1.21 (0.72–2.01)   |     0.563 |
+----------------------------------+----------------+----------------+--------------------+-----------+
| Hypertension, n (%)              | 40 (47.1%)     | 119 (27.3%)    | 2.34 (1.40–3.91)   |     0.001 |
+----------------------------------+----------------+----------------+--------------------+-----------+
| Congestive Heart Failure, n (%)  | 51 (60.0%)     | 93 (21.3%)     | 5.59 (3.31–9.42)   |     0     |
+----------------------------------+----------------+----------------+--------------------+-----------+
| Prior CVA/TIA, n (%)             | 15 (17.6%)     | 23 (5.3%)      | 3.91 (1.94–7.90)   |     0     |
+----------------------------------+----------------+----------------+--------------------+-----------+
| Diabetes Mellitus, n (%)         | 29 (34.1%)     | 70 (16.1%)     | 2.81 (1.66–4.77)   |     0     |
+----------------------------------+----------------+----------------+--------------------+-----------+
| Vascular Disease, n (%)          | 27 (31.8%)     | 65 (14.9%)     | 2.53 (1.48–4.32)   |     0.001 |
+----------------------------------+----------------+----------------+--------------------+-----------+
| Spontaneous Echo Contrast, n (%) | 76 (89.4%)     | 180 (41.3%)    | 10.41 (5.08–21.36) |     0     |
+----------------------------------+----------------+----------------+--------------------+-----------+
| CHADS2, median (IQR)             | 2 (1–3)        | 1 (0–2)        | —                  |     0     |
+----------------------------------+----------------+----------------+--------------------+-----------+
| CHA2DS2-VASc, median (IQR)       | 3 (2–5)        | 2 (1–3)        | —                  |     0     |
+----------------------------------+----------------+----------------+--------------------+-----------+